Clinical trial

Assessment of CCM in HF With Higher Ejection Fraction

NCT05064709

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-02-03

PhaseNA

Study timeline

Study start (actual)2022-02-03Date precision: day

Registry last updated2026-08-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Heart Failure With Preserved Ejection Fractionunresolved

Heart Failure With Mid Range Ejection Fractionunresolved

Heart Failure With Moderately Reduced Ejection Fractionunresolved

Diastolic Heart Failureunresolved

Interventions

Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini SystemDEVICE

OPTIMIZER™ Smart Mini SystemDEVICE

Sponsors & collaborators

Impulse Dynamicslead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States4 HoustonTexas, United States3 AustinTexas, United States3 MesaArizona, United States3 Los AngelesCalifornia, United States2 DallasTexas, United States2 ClevelandOhio, United States2 PittsburghPennsylvania, United States2 ColumbusOhio, United States2 IndianapolisIndiana, United States2 PhoenixArizona, United States2 OrlandoFlorida, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05064709 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.